• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管衰老的轨迹——从分子机制到临床应用

Trajectories of cardiovascular ageing - from molecular mechanisms to clinical implementation.

作者信息

Ministrini Stefano, Wenzl Florian A, Lüscher Thomas F, Camici Giovanni G

机构信息

Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.

Royal Brompton and Harefield Hospitals, Imperial College and King's College, London, United Kingdom.

出版信息

Cardiovasc Res. 2024 Aug 23. doi: 10.1093/cvr/cvae178.

DOI:10.1093/cvr/cvae178
PMID:39177254
Abstract

Due to its peculiar structure and function, the cardiovascular system is particularly vulnerable to the detrimental effects of ageing. Current knowledge about the molecular mechanisms of ageing revealed the processes actively promoting ageing, e.g. progressive telomeres shortening, and the mechanisms opposing it, e.g. endogenous production of antioxidant substances. This knowledge can be used to measure biological age at a cellular and molecular level and to interfere with it by pharmacological or non-pharmacological interventions. Biological ageing is determined by the simultaneous occurrence of independent hallmarks, which encompass a wide range of biological processes, from genomic changes to systemic inflammation and dysbiosis. This narrative review will summarize the role of ageing hallmarks in the cardiovascular system, how they can be measured and what are the possible interventions to counteract their effects.

摘要

由于其独特的结构和功能,心血管系统特别容易受到衰老的有害影响。目前关于衰老分子机制的知识揭示了积极促进衰老的过程,如端粒逐渐缩短,以及与之相反的机制,如抗氧化物质的内源性产生。这些知识可用于在细胞和分子水平上测量生物学年龄,并通过药物或非药物干预来加以干预。生物学衰老由多种独立特征同时出现所决定,这些特征涵盖了从基因组变化到全身炎症和微生物群失调等广泛的生物学过程。这篇叙述性综述将总结衰老特征在心血管系统中的作用、如何对其进行测量以及有哪些可能的干预措施来抵消其影响。

相似文献

1
Trajectories of cardiovascular ageing - from molecular mechanisms to clinical implementation.心血管衰老的轨迹——从分子机制到临床应用
Cardiovasc Res. 2024 Aug 23. doi: 10.1093/cvr/cvae178.
2
Anti-ageing interventions for the treatment of cardiovascular disease.用于治疗心血管疾病的抗衰老干预措施。
Cardiovasc Res. 2024 Aug 22. doi: 10.1093/cvr/cvae177.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Speech changes in old age: Methodological considerations for speech-based discrimination of healthy ageing and Alzheimer's disease.老年言语变化:基于言语的健康衰老与阿尔茨海默病鉴别方法学的考虑。
Int J Lang Commun Disord. 2024 Jan-Feb;59(1):13-37. doi: 10.1111/1460-6984.12888. Epub 2023 May 4.
5
From sex hormone decrease to hormonal treatment: impacts on cardiovascular risk with ageing.从性激素减少到激素治疗:衰老对心血管风险的影响
Cardiovasc Res. 2025 Aug 28;121(10):1551-1565. doi: 10.1093/cvr/cvaf086.
6
How to measure and model cardiovascular aging.如何测量和模拟心血管衰老。
Cardiovasc Res. 2025 Aug 28;121(10):1489-1508. doi: 10.1093/cvr/cvaf138.
7
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.在自闭症群体的参与下为成年自闭症患者调整安全计划。
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
8
Roadmap for alleviating the manifestations of ageing in the cardiovascular system.减轻心血管系统衰老表现的路线图。
Nat Rev Cardiol. 2025 Feb 19. doi: 10.1038/s41569-025-01130-5.
9
"In a State of Flow": A Qualitative Examination of Autistic Adults' Phenomenological Experiences of Task Immersion.“心流状态”:对自闭症成年人任务沉浸现象学体验的质性研究
Autism Adulthood. 2024 Sep 16;6(3):362-373. doi: 10.1089/aut.2023.0032. eCollection 2024 Sep.
10
Patient Restraint and Seclusion患者约束与隔离

引用本文的文献

1
Anti-senescence therapies: a new concept to address cardiovascular disease.抗衰老疗法:应对心血管疾病的新概念。
Cardiovasc Res. 2025 May 23;121(5):730-747. doi: 10.1093/cvr/cvaf030.

本文引用的文献

1
Associations of Circulating Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 With Long-Term Cardiac Function.循环血管细胞黏附分子-1 和细胞间黏附分子-1 与长期心脏功能的相关性。
J Am Heart Assoc. 2024 Mar 19;13(6):e032213. doi: 10.1161/JAHA.123.032213. Epub 2024 Mar 18.
2
Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results.治疗性靶向糖尿病性黄斑水肿中的细胞衰老:临床前和 1 期试验结果。
Nat Med. 2024 Feb;30(2):443-454. doi: 10.1038/s41591-024-02802-4. Epub 2024 Feb 6.
3
ROS production by mitochondria: function or dysfunction?
线粒体产生 ROS:功能还是障碍?
Oncogene. 2024 Jan;43(5):295-303. doi: 10.1038/s41388-023-02907-z. Epub 2023 Dec 11.
4
The effects of the ketogenic diet for the management of type 2 diabetes mellitus: A systematic review and meta-analysis of recent studies.生酮饮食治疗 2 型糖尿病的效果:近期研究的系统评价和荟萃分析。
Diabetes Metab Syndr. 2023 Dec;17(12):102905. doi: 10.1016/j.dsx.2023.102905. Epub 2023 Nov 15.
5
Long non-coding RNAs H19 and NKILA are associated with the risk of death and lacunar stroke in the elderly population.长链非编码 RNA H19 和 NKILA 与老年人群的死亡和腔隙性卒中风险相关。
Eur J Intern Med. 2024 May;123:94-101. doi: 10.1016/j.ejim.2023.11.013. Epub 2023 Nov 18.
6
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.司美格鲁肽在肥胖但无糖尿病患者中的心血管结局。
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.
7
NAD rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis.NAD 通过 CX43-PARP1 轴挽救衰老引起的血脑屏障损伤。
Neuron. 2023 Nov 15;111(22):3634-3649.e7. doi: 10.1016/j.neuron.2023.08.010. Epub 2023 Sep 7.
8
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.轻度阿尔茨海默病的衰老细胞清除疗法:1 期可行性试验。
Nat Med. 2023 Oct;29(10):2481-2488. doi: 10.1038/s41591-023-02543-w. Epub 2023 Sep 7.
9
Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.肠道微生物衍生芳香族氨基酸产物图谱与心血管疾病发病和死亡风险
Eur Heart J. 2023 Aug 22;44(32):3085-3096. doi: 10.1093/eurheartj/ehad333.
10
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study.亚临床动脉粥样硬化和炎症介导的表观遗传年龄加速:一项多组学研究。
Eur Heart J. 2023 Aug 1;44(29):2698-2709. doi: 10.1093/eurheartj/ehad361.